HC2 Announces That Genovel Orthopedics, Inc. Enters Into a Research and License Agreement With New York University
- Press Release for marketwatch.com May 21st, 2014
- Source: http://www.marketwatch.com/story/hc2-announces-that-genovel-orthopedics-inc-enters-into-a-research-and-license-agreement-with-new-york-university-2014-05-21
HC2 Holdings, Inc. ("HC2") (otcqb:HCHC) announced today that Genovel Orthopedics, Inc. ("Genovel") signed a research and license agreement with New York University for the development and commercialization of a new technology for osteoarthritis of the knee.
Genovel is a Delaware company founded by Pansend, LLC, a wholly owned subsidiary of HC2 Holdings, Inc.
The technology was designed by Peter S. Walker, PhD; Professor, Department of Orthopaedic Surgery, NYU School of Medicine; Professor, Department of Mechanical & Aerospace Engineering, NYU-Polytechnic and Joseph Bosco, MD, Associate Professor; Vice Chair for Clinical Affairs, Department of Orthopaedic Surgery, NYU School of Medicine. They have designed a next-generation treatment for patients who suffer from osteoarthritis of the knee that seeks to improve their quality of life and lower costs.
